company background image
A176750 logo

DuChemBIOLtd XKON:A176750 Stock Report

Last Price

₩14.30k

Market Cap

₩385.9b

7D

-8.7%

1Y

160.0%

Updated

05 Dec, 2024

Data

Company Financials +

A176750 Stock Overview

Engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. More details

A176750 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis


DuChemBIO Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DuChemBIOLtd
Historical stock prices
Current Share Price₩14,300.00
52 Week High₩19,570.00
52 Week Low₩5,050.00
Beta0
11 Month Change-17.86%
3 Month Change11.63%
1 Year Change160.00%
33 Year Change76.54%
5 Year Change44.01%
Change since IPO35.55%

Recent News & Updates

Recent updates

Shareholder Returns

A176750KR Medical EquipmentKR Market
7D-8.7%-3.0%-1.8%
1Y160.0%8.3%-4.3%

Return vs Industry: A176750 exceeded the KR Medical Equipment industry which returned 8.3% over the past year.

Return vs Market: A176750 exceeded the KR Market which returned -4.3% over the past year.

Price Volatility

Is A176750's price volatile compared to industry and market?
A176750 volatility
A176750 Average Weekly Movement7.4%
Medical Equipment Industry Average Movement7.0%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.8%
10% least volatile stocks in KR Market2.8%

Stable Share Price: A176750 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A176750's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002n/an/awww.duchembio.com

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amyloid in Alzheimer's disease.

DuChemBIO Co.,Ltd. Fundamentals Summary

How do DuChemBIOLtd's earnings and revenue compare to its market cap?
A176750 fundamental statistics
Market cap₩385.91b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A176750 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A176750 perform over the long term?

See historical performance and comparison